Report Detail

Service & Software Global Biopharmaceutical 3PL Market Size, Status and Forecast 2021-2027

  • RnM4302376
  • |
  • 07 April, 2021
  • |
  • Global
  • |
  • 108 Pages
  • |
  • QYResearch
  • |
  • Service & Software

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Biopharmaceutical 3PL Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Cold Chain
    • 1.2.3 Non-cold Chain
  • 1.3 Market by Application
    • 1.3.1 Global Biopharmaceutical 3PL Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Transportation
    • 1.3.3 Warehousing and Storage
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Biopharmaceutical 3PL Market Perspective (2016-2027)
  • 2.2 Biopharmaceutical 3PL Growth Trends by Regions
    • 2.2.1 Biopharmaceutical 3PL Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Biopharmaceutical 3PL Historic Market Share by Regions (2016-2021)
    • 2.2.3 Biopharmaceutical 3PL Forecasted Market Size by Regions (2022-2027)
  • 2.3 Biopharmaceutical 3PL Industry Dynamic
    • 2.3.1 Biopharmaceutical 3PL Market Trends
    • 2.3.2 Biopharmaceutical 3PL Market Drivers
    • 2.3.3 Biopharmaceutical 3PL Market Challenges
    • 2.3.4 Biopharmaceutical 3PL Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Biopharmaceutical 3PL Players by Revenue
    • 3.1.1 Global Top Biopharmaceutical 3PL Players by Revenue (2016-2021)
    • 3.1.2 Global Biopharmaceutical 3PL Revenue Market Share by Players (2016-2021)
  • 3.2 Global Biopharmaceutical 3PL Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Biopharmaceutical 3PL Revenue
  • 3.4 Global Biopharmaceutical 3PL Market Concentration Ratio
    • 3.4.1 Global Biopharmaceutical 3PL Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical 3PL Revenue in 2020
  • 3.5 Biopharmaceutical 3PL Key Players Head office and Area Served
  • 3.6 Key Players Biopharmaceutical 3PL Product Solution and Service
  • 3.7 Date of Enter into Biopharmaceutical 3PL Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical 3PL Breakdown Data by Type

  • 4.1 Global Biopharmaceutical 3PL Historic Market Size by Type (2016-2021)
  • 4.2 Global Biopharmaceutical 3PL Forecasted Market Size by Type (2022-2027)

5 Biopharmaceutical 3PL Breakdown Data by Application

  • 5.1 Global Biopharmaceutical 3PL Historic Market Size by Application (2016-2021)
  • 5.2 Global Biopharmaceutical 3PL Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Biopharmaceutical 3PL Market Size (2016-2027)
  • 6.2 North America Biopharmaceutical 3PL Market Size by Type
    • 6.2.1 North America Biopharmaceutical 3PL Market Size by Type (2016-2021)
    • 6.2.2 North America Biopharmaceutical 3PL Market Size by Type (2022-2027)
    • 6.2.3 North America Biopharmaceutical 3PL Market Size by Type (2016-2027)
  • 6.3 North America Biopharmaceutical 3PL Market Size by Application
    • 6.3.1 North America Biopharmaceutical 3PL Market Size by Application (2016-2021)
    • 6.3.2 North America Biopharmaceutical 3PL Market Size by Application (2022-2027)
    • 6.3.3 North America Biopharmaceutical 3PL Market Size by Application (2016-2027)
  • 6.4 North America Biopharmaceutical 3PL Market Size by Country
    • 6.4.1 North America Biopharmaceutical 3PL Market Size by Country (2016-2021)
    • 6.4.2 North America Biopharmaceutical 3PL Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Biopharmaceutical 3PL Market Size (2016-2027)
  • 7.2 Europe Biopharmaceutical 3PL Market Size by Type
    • 7.2.1 Europe Biopharmaceutical 3PL Market Size by Type (2016-2021)
    • 7.2.2 Europe Biopharmaceutical 3PL Market Size by Type (2022-2027)
    • 7.2.3 Europe Biopharmaceutical 3PL Market Size by Type (2016-2027)
  • 7.3 Europe Biopharmaceutical 3PL Market Size by Application
    • 7.3.1 Europe Biopharmaceutical 3PL Market Size by Application (2016-2021)
    • 7.3.2 Europe Biopharmaceutical 3PL Market Size by Application (2022-2027)
    • 7.3.3 Europe Biopharmaceutical 3PL Market Size by Application (2016-2027)
  • 7.4 Europe Biopharmaceutical 3PL Market Size by Country
    • 7.4.1 Europe Biopharmaceutical 3PL Market Size by Country (2016-2021)
    • 7.4.2 Europe Biopharmaceutical 3PL Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Biopharmaceutical 3PL Market Size (2016-2027)
  • 8.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Type
    • 8.2.1 Asia-Pacific Biopharmaceutical 3PL Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Application
    • 8.3.1 Asia-Pacific Biopharmaceutical 3PL Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Biopharmaceutical 3PL Market Size by Region
    • 8.4.1 Asia-Pacific Biopharmaceutical 3PL Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Biopharmaceutical 3PL Market Size (2016-2027)
  • 9.2 Latin America Biopharmaceutical 3PL Market Size by Type
    • 9.2.1 Latin America Biopharmaceutical 3PL Market Size by Type (2016-2021)
    • 9.2.2 Latin America Biopharmaceutical 3PL Market Size by Type (2022-2027)
    • 9.2.3 Latin America Biopharmaceutical 3PL Market Size by Type (2016-2027)
  • 9.3 Latin America Biopharmaceutical 3PL Market Size by Application
    • 9.3.1 Latin America Biopharmaceutical 3PL Market Size by Application (2016-2021)
    • 9.3.2 Latin America Biopharmaceutical 3PL Market Size by Application (2022-2027)
    • 9.3.3 Latin America Biopharmaceutical 3PL Market Size by Application (2016-2027)
  • 9.4 Latin America Biopharmaceutical 3PL Market Size by Country
    • 9.4.1 Latin America Biopharmaceutical 3PL Market Size by Country (2016-2021)
    • 9.4.2 Latin America Biopharmaceutical 3PL Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Biopharmaceutical 3PL Market Size (2016-2027)
  • 10.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Type
    • 10.2.1 Middle East & Africa Biopharmaceutical 3PL Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Application
    • 10.3.1 Middle East & Africa Biopharmaceutical 3PL Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Biopharmaceutical 3PL Market Size by Country
    • 10.4.1 Middle East & Africa Biopharmaceutical 3PL Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 FedEx.
    • 11.1.1 FedEx. Company Details
    • 11.1.2 FedEx. Business Overview
    • 11.1.3 FedEx. Biopharmaceutical 3PL Introduction
    • 11.1.4 FedEx. Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.1.5 FedEx. Recent Development
  • 11.2 DHL International GmbH
    • 11.2.1 DHL International GmbH Company Details
    • 11.2.2 DHL International GmbH Business Overview
    • 11.2.3 DHL International GmbH Biopharmaceutical 3PL Introduction
    • 11.2.4 DHL International GmbH Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.2.5 DHL International GmbH Recent Development
  • 11.3 SF Express
    • 11.3.1 SF Express Company Details
    • 11.3.2 SF Express Business Overview
    • 11.3.3 SF Express Biopharmaceutical 3PL Introduction
    • 11.3.4 SF Express Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.3.5 SF Express Recent Development
  • 11.4 United Parcel Service of America, Inc.
    • 11.4.1 United Parcel Service of America, Inc. Company Details
    • 11.4.2 United Parcel Service of America, Inc. Business Overview
    • 11.4.3 United Parcel Service of America, Inc. Biopharmaceutical 3PL Introduction
    • 11.4.4 United Parcel Service of America, Inc. Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.4.5 United Parcel Service of America, Inc. Recent Development
  • 11.5 AmerisourceBergen Corporation
    • 11.5.1 AmerisourceBergen Corporation Company Details
    • 11.5.2 AmerisourceBergen Corporation Business Overview
    • 11.5.3 AmerisourceBergen Corporation Biopharmaceutical 3PL Introduction
    • 11.5.4 AmerisourceBergen Corporation Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.5.5 AmerisourceBergen Corporation Recent Development
  • 11.6 DB Schenker
    • 11.6.1 DB Schenker Company Details
    • 11.6.2 DB Schenker Business Overview
    • 11.6.3 DB Schenker Biopharmaceutical 3PL Introduction
    • 11.6.4 DB Schenker Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.6.5 DB Schenker Recent Development
  • 11.7 KUEHNE + NAGEL
    • 11.7.1 KUEHNE + NAGEL Company Details
    • 11.7.2 KUEHNE + NAGEL Business Overview
    • 11.7.3 KUEHNE + NAGEL Biopharmaceutical 3PL Introduction
    • 11.7.4 KUEHNE + NAGEL Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.7.5 KUEHNE + NAGEL Recent Development
  • 11.8 Kerry Logistics Network Limited
    • 11.8.1 Kerry Logistics Network Limited Company Details
    • 11.8.2 Kerry Logistics Network Limited Business Overview
    • 11.8.3 Kerry Logistics Network Limited Biopharmaceutical 3PL Introduction
    • 11.8.4 Kerry Logistics Network Limited Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.8.5 Kerry Logistics Network Limited Recent Development
  • 11.9 Agility
    • 11.9.1 Agility Company Details
    • 11.9.2 Agility Business Overview
    • 11.9.3 Agility Biopharmaceutical 3PL Introduction
    • 11.9.4 Agility Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.9.5 Agility Recent Development
  • 11.10 EMS
    • 11.10.1 EMS Company Details
    • 11.10.2 EMS Business Overview
    • 11.10.3 EMS Biopharmaceutical 3PL Introduction
    • 11.10.4 EMS Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.10.5 EMS Recent Development
  • 11.11 SF Express
    • 11.11.1 SF Express Company Details
    • 11.11.2 SF Express Business Overview
    • 11.11.3 SF Express Biopharmaceutical 3PL Introduction
    • 11.11.4 SF Express Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.11.5 SF Express Recent Development
  • 11.12 Jd.Com, Inc.
    • 11.12.1 Jd.Com, Inc. Company Details
    • 11.12.2 Jd.Com, Inc. Business Overview
    • 11.12.3 Jd.Com, Inc. Biopharmaceutical 3PL Introduction
    • 11.12.4 Jd.Com, Inc. Revenue in Biopharmaceutical 3PL Business (2016-2021)
    • 11.12.5 Jd.Com, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Biopharmaceutical 3PL Scope and Market Size
    Biopharmaceutical 3PL market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical 3PL market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Cold Chain
    Non-cold Chain

    Segment by Application
    Transportation
    Warehousing and Storage
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    FedEx.
    DHL International GmbH
    SF Express
    United Parcel Service of America, Inc.
    AmerisourceBergen Corporation
    DB Schenker
    KUEHNE + NAGEL
    Kerry Logistics Network Limited
    Agility
    EMS
    SF Express
    Jd.Com, Inc.


    Summary:
    Get latest Market Research Reports on Biopharmaceutical 3PL. Industry analysis & Market Report on Biopharmaceutical 3PL is a syndicated market report, published as Global Biopharmaceutical 3PL Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Biopharmaceutical 3PL market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,836.02
    4,254.03
    5,672.04
    3,271.52
    4,907.27
    6,543.03
    426,909.60
    640,364.40
    853,819.20
    292,334.25
    438,501.38
    584,668.50
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report